title: [Long-term outcome of surgical treatment of patients with esophageal cancer].
abstract: Under study were the results of surgical treatment of 185 patients with esophageal carcinoma. One-year survival was 75.4%, 2-year survival was 49.6%, 3-year--43.4%, and 4-year survival--33.3%. Among the patients with tumors with the invasion degree T1, T2, T3 and having no metastases to the regional lymph nodes the resection of the esophagus in combination with the extended lympho dissection resulted in 4-year survival in more than 50% of the patients operated upon. In patients with tumors T3N1, T4N1 and especially with the simultaneous involvement of several lymph collectors the 4-year survival was 21.4%. The operative intervention at this stage of the disease should be considered as a palliative means in the greater part of the patients.
authors.forename: B I
authors.initials: BI
authors.lastname: Miroshnikov
authors.forename: K V
authors.initials: KV
authors.lastname: Pavelets
authors.forename: N E
authors.initials: NE
authors.lastname: Marochkin
authors.forename: L D
authors.initials: LD
authors.lastname: Roman
authors.forename: K G
authors.initials: KG
authors.lastname: Shostka
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Shiriaev
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D013997:Time Factors; D016896:Treatment Outcome